Marker Therapeutics Inc (MRKR)
3.71
+0.19
(+5.40%)
USD |
NASDAQ |
Nov 05, 14:48
Marker Therapeutics Price to Book Value: 3.412 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.237 |
| November 01, 2024 | 3.366 |
| October 31, 2024 | 3.724 |
| October 30, 2024 | 3.743 |
| October 29, 2024 | 3.761 |
| October 28, 2024 | 3.973 |
| October 25, 2024 | 3.977 |
| October 24, 2024 | 3.688 |
| October 23, 2024 | 4.147 |
| October 22, 2024 | 4.175 |
| October 21, 2024 | 3.402 |
| October 18, 2024 | 3.237 |
| October 17, 2024 | 2.989 |
| October 16, 2024 | 3.237 |
| October 15, 2024 | 3.007 |
| October 14, 2024 | 3.118 |
| October 11, 2024 | 2.492 |
| October 10, 2024 | 2.290 |
| October 09, 2024 | 2.409 |
| October 08, 2024 | 2.419 |
| October 07, 2024 | 2.556 |
| October 04, 2024 | 2.575 |
| October 03, 2024 | 2.440 |
| October 02, 2024 | 2.382 |
| October 01, 2024 | 2.492 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.593 |
| September 27, 2024 | 2.667 |
| September 26, 2024 | 2.529 |
| September 25, 2024 | 2.373 |
| September 24, 2024 | 2.446 |
| September 23, 2024 | 2.391 |
| September 20, 2024 | 2.704 |
| September 19, 2024 | 2.694 |
| September 18, 2024 | 2.547 |
| September 17, 2024 | 2.566 |
| September 16, 2024 | 2.648 |
| September 13, 2024 | 2.551 |
| September 12, 2024 | 2.483 |
| September 11, 2024 | 2.556 |
| September 10, 2024 | 2.483 |
| September 09, 2024 | 2.836 |
| September 06, 2024 | 2.740 |
| September 05, 2024 | 2.878 |
| September 04, 2024 | 2.832 |
| September 03, 2024 | 2.796 |
| August 30, 2024 | 3.320 |
| August 29, 2024 | 3.219 |
| August 28, 2024 | 3.255 |
| August 27, 2024 | 3.329 |
| August 26, 2024 | 3.402 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3494
Minimum
Mar 30 2023
8.682
Maximum
Mar 22 2021
2.302
Average
2.419
Median
Oct 08 2024
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.567 |
| Perspective Therapeutics Inc | 2.389 |
| Protalix BioTherapeutics Inc | 3.294 |
| Electromed Inc | 4.535 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 3.71 |
| Earnings Yield | -31.81% |
| Market Cap | 33.10M |